Contraindicated in:
Use Cautiously in:
CNS: headache (↑in children 1317 yr).
EENT: oropharyngeal pain (↑ in children 1317 yr).
GI: abdominal pain (↑ in children 1317 yr), diarrhea, nausea.
Misc: HYPERSENSITIVITY REACTIONS INCLUDING ANAPHYLAXIS AND EXACERBATION OF HAE.
Therapeutic Classification: replacement enzyme inhibitors
Pharmacologic Classification: enzyme inhibitors
Absorption: IV administration results in complete bioavailability.
Distribution: Unknown.
Metabolism/Excretion: Unknown.
Half-life: 2.42.7 hr.